Is indocyanine green angiography still relevant?

Retina

Volumn 31, Issue 2, 2011, Pages 209-221

  Cohen, Salomon Y ^a,b   Dubois, Lise ^a   Quentel, Gabriel ^a   Gaudric, Alain ^b  

^a Centre Ophtalmologique d'Imagerie et de Laser   (France)

^b HÔPITAL LARIBOISIÈRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDOCYANINE GREEN; RANIBIZUMAB; VASCULOTROPIN ANTIBODY;

CENTRAL SEROUS RETINOPATHY; CHORIORETINOPATHY; CHOROID TUMOR; CHOROIDITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; FLUORESCENCE ANGIOGRAPHY; HISTORY OF MEDICINE; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; INTERMETHOD COMPARISON; LICHEN SCLEROSUS ET ATROPHICUS; MYOPIA; POLYPOIDAL CHOROIDAL VASCULOPATHY; RETINA DISEASE; RETINA DYSTROPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINA PIGMENT EPITHELIOPATHY; REVIEW; SARCOIDOSIS; SCANNING LASER OPHTHALMOSCOPY; SUBRETINAL NEOVASCULARIZATION; TREATMENT INDICATION; TUMOR DIFFERENTIATION; VOGT KOYANAGI SYNDROME;

BLOOD FLOW VELOCITY; CHOROID; CHOROID DISEASES; COLORING AGENTS; FLUORESCEIN ANGIOGRAPHY; HUMANS; INDOCYANINE GREEN; REGIONAL BLOOD FLOW;

EID: 79551521157     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820a69db     Document Type: Review

References (210)

1. Flower RW, Yannuzzi LA, Slakter JS. History of indocyanine green angiography. In: Yannuzzi LA, Flower RW, Slakter JS. Indocyanine Green Angiography. St Louis, MO: Mosby; 1997:2-17.
2. Hochheimer BF. Angiography of the retina with indocyanine green. Arch Ophthalmol 1971;86:564-565.
3. Flower RW, Hochheimer BF. A clinical technique and apparatus for simultaneous angiography of the separate retinal and choroidal circulations. Invest Ophthalmol Vis Sci 1973;12:248-261.
4. Quentel G, Coscas G. Infrared fluorescein angiography using indocyanine green [French]. Bull Soc Ophtalmol Fr 1984;84: 559-563.
5. Bischoff PM, Flower RW. Ten years experience with choroidal angiography using indocyanine green dye: A new routine examination or an epilogue? Doc Ophthalmol 1985;60:235-291.
6. Hayashi K, Hasegawa Y, Tokoro T, De Laey JJ. Value of indocyanine green angiography in the diagnosis of occult choroidal neovascular membrane. Jpn J Clin Ophthalmol 1988;42:827-829.
7. Hayashi K, Hasegawa Y, Tokoro T, De Laey JJ. Clinical application of indocyanine green angiography to occult choroidal neovascularisation. Jpn J Clin Ophthalmol 1989;43:57-65.
8. Destro M, Puliafito CA. Indocyanine green videoangiography of choroidal neovascularization. Ophthalmology 1989;96:846-853.
9. Guyer DR, Puliafito CA, Monés JM, Friedman E, Chang W, Verdooner SR. Digital indocyanine-green angiography in chorioretinal disorders. Ophthalmology 1992;99:287-291.
10. Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR, Orlock DA. Digital indocyanine green videoangiography and choroidal neovascularization. Retina. 1992;12:191-223.
11. Sorenson JA, Yannuzzi LA, Slakter JS, Guyer DR, Ho AC, Orlock DA. A pilot study of digital indocyanine green videoangiography for recurrent occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994;112:473-479.
12. Slakter JS, Yannuzzi LA, Sorenson JA, Guyer DR, Ho AC, Orlock DA. A pilot study of indocyanine green videoangiography- guided laser photocoagulation of occult choroidal neovascularization in age-related macular degeneration. Arch Ophthalmol 1994;112:465-472.
13. Yannuzzi LA, Hope-Ross M, Slakter JS, et al. Analysis of vascularized pigment epithelial detachments using indocyanine green videoangiography. Retina 1994;14:99-113.
14. Kuhn D, Meunier I, Soubrane G, Coscas G. Imaging of chorioretinal anastomoses in vascularized retinal pigment epithelium detachments. Arch Ophthalmol 1995;113:1392-1398.
15. Costa RA, Farah ME, Cardillo JA, Belfort R Jr. Photodynamic therapy with indocyanine green for occult subfoveal choroidal neovascularization caused by age-related macular degeneration. Curr Eye Res 2001;23:271-275.
16. Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000;118:1116-1118.
17. Kusaka S, Hayashi N, Ohji M, Hayashi A, Kamei M, Tano Y. Indocyanine green facilitates removal of epiretinal and internal limiting membranes in myopic eyes with retinal detachment. Am J Ophthalmol 2001;131:388-390.
18. Arnold JJ, Quaranta M, Soubrane G, Sarks SH, Coscas G. Indocyanine green angiography of drusen. Am J Ophthalmol 1997;124:344-356.
19. ChangAA, Guyer DR, Orlock DR,Yannuzzi LA.Age-dependent variations in the drusen fluorescence on indocyanine green angiography. Clin Experiment Ophthalmol 2003;31:300-304.
20. Quaranta M, Buglione M, Lo Schiavo Elia R, Coscas G, Soubrane G. Indocyanine green angiography of basal laminar drusen in the retinal pigment epithelium associated with vitelliform macular degeneration [French]. J Fr Ophtalmol 1998;21:185-190.
21. Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP. Reticular pseudodrusen. A risk factor in age-related maculopathy. Retina 1995;15:183-191.
22. Smith RT, Sohrab MA, Busuioc M, Barile G. Reticular macular disease. Am J Ophthalmol 2009;148:733-743.
23. Yannuzzi LA, Negrão S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-434.
24. Freund KB, Ho IV, Barbazetto IA, et al. Type 3 neovascularization: The expanded spectrum of retinal angiomatous proliferation. Retina 2008;28:201-211.
25. Shiraga F, Ojima Y, Matsuo T, Takasu I, Matsuo N. Feeder vessel photocoagulation of subfoveal choroidal neovascularization secondary to age-related macular degeneration. Ophthalmology 1998;105:662-669.
26. Flower RW. Experimental studies of indocyanine green dyeenhanced photocoagulation of choroidal neovascularization feeder vessels. Am J Ophthalmol 2000;129:501-512.
27. Desatnik H, Treister G, Alhalel A, Krupsky S, Moisseiev J. ICGA-guided laser photocoagulation of feeder vessels of choroidal neovascular membranes in age-related macular degeneration. Indocyanine green angiography. Retina 2000; 20:143-150.
28. Lafaut BA, Bartz-Schmidt KU, Vanden Broecke C, Aisenbrey S, De Laey JJ, Heimann K. Clinicopathological correlation in exudative age related macular degeneration: Histological differentiation between classic and occult choroidal neovascularisation. Br J Ophthalmol 2000;84:239-243.
29. Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001;119:198-207.
30. Verteporfin In Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in agerelated macular degeneration: Two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. Am J Ophthalmol 2001;131:541-560.
31. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-1431.
32. Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus verteporfin for neovascular age related macular degeneration. N Engl J Med 2006;355:1432-1444.
33. Arias L. Treatment of retinal pigment epithelial detachment with antiangiogenic therapy. Clin Ophthalmol 2010;4:369-374.
34. Gass JD, Agarwal A, Lavina AM, Tawansy KA. Focal inner retinal hemorrhages in patients with drusen: An early sign of occult choroidal neovascularization and chorioretinal anastomosis. Retina 2003;23:741-751.
35. Matsumoto H, Sato T, Kishi S. Tomographic features of intraretinal neovascularization in retinal angiomatous proliferation. Retina 2010;30:425-430.
36. Spaide RF. Enhanced depth imaging optical coherence tomography of retinal pigment epithelial detachment in age-related macular degeneration. Am J Ophthalmol 2009;147:644-652.
37. Keane PA, Sadda SR. Imaging chorioretinal vascular disease. Eye (Lond) 2010;24:422-427.
38. Puliafito CA. A brief history of optical coherence tomography: A personal perspective. Ophthalmic Surg Lasers Imaging 2009;40:94-95.
39. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-583.
40. Spaide RF. The as-needed treatment strategy for choroidal neovascularization: A feedback-based treatment system. Am J Ophthalmol 2009;148:1-3.
41. Cohen SY, Dubois L, Tadayoni R, et al. Results of one-year's treatment with ranibizumab for exudative age related macular degeneration in a clinical setting. Am J Ophthalmol 2009; 148:409-413.
42. Kang S, Roh YJ. One-year results of intravitreal ranibizumab for neovascular age-related macular degeneration and clinical responses of various subgroups. Jpn J Ophthalmol 2009;53: 389-395.
43. Rothenbuehler SP, Waeber D, Brinkmann CK, Wolf S, Wolf- Schnurrbusch UE. Effects of ranibizumab in patients with subfoveal choroidal neovascularization attributable to agerelated macular degeneration. Am J Ophthalmol 2009;147: 831-837.
44. Harding SP. Neovascular age-related macular degeneration: Decision making and optimal management. Eye (Lond) 2010; 24:497-505.
45. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology 1996;103:1241-1244.
46. Arend O, Remky A, Elsner AE, Wolf S, Rein M. Indocyanine green angiography in traumatic choroidal rupture: Clinicoangiographic case reports. Ger J Ophthalmol 1995;4:257-263.
47. Axer-Siegel R, Cotlear D, Priel E, Rosenblatt I, Snir M, Weinberger D. Indocyanine green angiography in high myopia. Ophthalmic Surg Lasers Imaging 2004;35:139-145.
48. Quaranta M, Arnold J, Coscas G, et al. Indocyanine green angiographic features of pathologic myopia. Am J Ophthalmol 1996;122:663-671.
49. Mutoh T, Sakurai M, Tamai M. Indocyanine green fundus angiography of retrobulbar vasculature. Arch Ophthalmol 1995;113:631-633.
50. Ohno-Matsui K, Morishima N, Ito M, Tokoro T. Indocyanine green angiographic findings of lacquer cracks in pathologic myopia. Jpn J Ophthalmol 1998;42:293-299.
51. Gaucher D, Erginay A, Lecleire-Collet A, et al. Dome-shaped macula in eyes with myopic posterior staphyloma. Am J Ophthalmol 2008;145:909-914.
52. Wakabayashi T, Ikuno Y. Choroidal filling delay in choroidal neovascularization due to pathologic myopia. Br J Ophthalmol 2010;94:611-615.
53. Sayanagi K, Ikuno Y, Soga K, Wakabayashi T, Tsujikawa M, Tano Y. Choroidal vascular hypofluorescence in indocyanine green angiography of high myopia. Br J Ophthalmol 2009;93: 1687-1690.
54. Kim DD, Pulido JS, Wipplinger WA. Indocyanine green angiographic findings in pseudoxanthoma elasticum. Am J Ophthalmol 1993;116:767-769.
55. Quaranta M, Cohen SY, Krott R, Sterkers M, Soubrane G, Coscas GJ. Indocyanine green videoangiography of angioid streaks. Am J Ophthalmol 1995;119:136-142.
56. Guzey M, Arvas S, Akar S, Ozkan S. Indocyanine green angiographic findings in young patients with Grönblad- Strandberg syndrome. Ophthalmologica 2001;215:22-29.
57. Shiraki K, Moriwaki M, Matsumoto M, Khono T, Miki T. Hypofluorescent spots in indocyanine green angiography of peau d'orange and fundus. Int Ophthalmol 1997;21:43-50.
58. Lafaut BA, Leys AM, Scassellati-Sforzolini B, Priem H, De Laey JJ. Comparison of fluorescein and indocyanine green angiography in angioid streaks. Graefes Arch Clin Exp Ophthalmol 1998;236:346-353.
59. Lee TK, Forooghian F, Cukras C, Wong WT, Chew EY, Meyerle CB. Complementary angiographic and autofluorescence findings in pseudoxanthoma elasticum. Int Ophthalmol 2010;30:77-79.
60. Yannuzzi LA, Sorenson J, Spaide RF, Lipson B. Idiopathic polypoidal choroidal vasculopathy (IPCV). Retina 1990;10:1-8.
61. Stern RM, Zakov ZN, Zegarra H, Gutman FA. Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women. Am J Ophthalmol 1985;100:560-569.
62. Spaide RF, Yannuzzi LA, Slakter JS, Sorenson J, Orlach DA. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995;15:100-110.
63. Lafaut BA, Leys AM, Snyers B, Rasquin F, De Laey JJ. Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000;238:752-759.
64. Shi XH, Wei WB, Tian B, et al. Analysis of clinical features of choroidal neovascularization [Chinese]. Zhonghua Yan Ke Za Zhi 2008;44:780-785.
65. Song SJ, Youm DJ, Chang Y, Yu HG. Age-related macular degeneration in a screened South Korean population: Prevalence, risk factors, and subtypes. Ophthalmic Epidemiol 2009;16:304-310.
66. Hikichi T, Ohtsuka H, Higuchi M, et al. Causes of macular serous retinal detachments in Japanese patients 40 years and older. Retina 2009;29:395-404.
67. Sho K, Takahashi K, Yamada H, et al. Polypoidal choroidal vasculopathy: Incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003;121:1392-1396.
68. Ciardella AP, Donsoff IM, Huang SJ, Costa DL, Yannuzzi LA. Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004;49:25-37.
69. Squirrell DM, Bacon JF, Brand CS. To investigate the prevalence of polypoidal choroidal vasculopathy in presumed age-related peripapillary subretinal neovascular membranes. Clin Experiment Ophthalmol 2009;37:368-372.
70. Okubo A, Abematsu N, Sakamoto T. Nasal and independent polypoidal lesions in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2009;247:421-425.
71. Tsujikawa A, Nakanishi H, Ojima Y, et al. Macular polypoidal choroidal vasculopathy with a remote lesion. Clin Experiment Ophthalmol 2008;36:817-823.
72. Yannuzzi LA, Freund KB, Goldbaum M, et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000;107:767-777.
73. Ahuja RM, Downes SM, Stanga PE, Koh AH, Vingerling JR, Bird AC. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001;108:1009-1010.
74. Sasahara M, Tsujikawa A, Musashi K, et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006;142:601-607.
75. Yannuzzi LA, Wong DW, Sforzolini BS, et al. Polypoidal choroidal vasculopathy and neovascularized age-related macular degeneration. Arch Ophthalmol 1999;117:1503-1510.
76. Maruko I, Iida T, Saito M, Nagayama D. Combined cases of polypoidal choroidal vasculopathy and typical age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2010;248:361-368.
77. Chen Y, Wen F, Sun Z, Wu D. Polypoidal choroidal vasculopathy coexisting with exudative age-related macular degeneration. Int Ophthalmol 2008;28:119-123.
78. Tsuchiya D, Yamamoto T, Kawasaki R, Yamashita H. Two-year visual outcomes after photodynamic therapy in age-related macular degeneration patients with or without polypoidal choroidal vasculopathy lesions. Retina 2009;29:960-965.
79. Iijima H, Imai M, Gohdo T, Tsukahara S. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999;127:301-305.
80. Sa HS, Cho HY, Kang SW. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Korean J Ophthalmol 2005;19:275-280.
81. Ojima Y, Hangai M, Sakamoto A, et al. Improved visualization of polypoidal choroidal vasculopathy lesions using spectral-domain optical coherence tomography. Retina 2009;29:52-59.
82. Sato T, Kishi S, Watanabe G, Matsumoto H, Mukai R. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007;27:589-594.
83. Saito M, Iida T, Nagayama D. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy. Retina 2008;28:459-464.
84. Rosen RB, Hathaway M, Rogers J, et al. Simultaneous OCT/SLO/ICG imaging. Invest Ophthalmol Vis Sci 2009;50: 851-860.
85. Eandi CM, Ober MD, Freund KB, Slakter JS, Yannuzzi LA. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007;27:825-831.
86. Windisch R,Windisch BK, Cruess AF. Use of fluorescein and indocyanine green angiography in polypoidal choroidal vasculopathy patients following photodynamic therapy. Can J Ophthalmol 2008;43:678-682.
87. Yamashiro K, Tsujikawa A, Nishida A, Mandai M, Kurimoto Y. Recurrence of polypoidal choroidal vasculopathy after photodynamic therapy. Jpn J Ophthalmol 2008;52:457-462.
88. Kang SW, Chung SE, Shin WJ, Lee JH. Polypoidal choroidal vasculopathy and late geographic hyperfluorescence on indocyanine green angiography. Br J Ophthalmol 2009;93: 759-764.
89. Byeon SH, Lew YJ, Lee SC, Kwon OW. Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy. Acta Ophthalmol 2010;88:660-668.
90. Zuo C, Wen F, Li J, et al. Functional changes following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2010;248:191-196.
91. Lee SY, Kim JG, Joe SG, Chung H, Yoon YH. The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J Ophthalmol 2008;22:92-99.
92. Gomi F, Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol 2008;19:208-212.
93. Gomi F, Sawa M, Sakaguchi H, et al. Efficacy of intravitreal bevacizumab for polypoidal choroidal vasculopathy. Br J Ophthalmol 2008;92:70-73.
94. Lai TY, Chan WM, Liu DT, Luk FO, Lam DS. Intravitreal bevacizumab (Avastin) with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008;92:661-666.
95. Cho M, Barbazetto IA, Freund KB. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 2009;148:70-78.
96. Hayashi K, Hasegawa Y, Tokoro T. Indocyanine green angiography of central serous chorioretinopathy. Int Ophthalmol 1986;9:37-41.
97. Iida T, Kishi S, Hagimura N, Shimizu K. Persistent and bilateral choroidal vascular abnormalities in central serous chorioretinopathy. Retina 1999;19:508-512.
98. Scheider A, Nasemann JE, Lund OE. Fluorescein and indocyanine green angiographies of central serous choroidopathy by scanning laser ophthalmoscopy. Am J Ophthalmol 1993;115:50-56.
99. Piccolino FC, Borgia L. Central serous chorioretinopathy and indocyanine green angiography. Retina 1994;14:231-242.
100. Guyer DR, Yannuzzi LA, Slakter JS, Sorenson JA, Ho A, Orlock D. Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol 1994;112: 1057-1062.
101. Tsujikawa A, Ojima Y, Yamashiro K, et al. Punctate hyperfluorescent spots associated with central serous chorioretinopathy as seen on indocyanine green angiography. Retina 2010;30:801-809.
102. Prünte C. Indocyanine green angiographic findings in central serous chorioretinopathy. Int Ophthalmol 1995;19:77-82.
103. Prünte C, Flammer J. Choroidal capillary and venous congestion in central serous chorioretinopathy. Am J Ophthalmol 1996;121:26-34.
104. Piccolino FC, Borgia L, Zinicola E, Zingirian M. Indocyanine green angiographic findings in central serous chorioretinopathy. Eye 1995;9:324-332.
105. Lafaut BA, Salati C, Priem H, De Laey JJ. Indocyanine green angiography is of value for the diagnosis of chronic central serous chorioretinopathy in elderly patients. Graefes Arch Clin Exp Ophthalmol 1998;236:513-521.
106. Imamura Y, Fujiwara T, Margolis R, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in central serous chorioretinopathy. Retina 2009;29:1469-1473.
107. Yannuzzi LA, Slakter JS, Gross NE, et al. Indocyanine green angiography-guided photodynamic therapy for treatment of chronic central serous chorioretinopathy: A pilot study. Retina 2003;23:288-298.
108. Chan WM, Lam DS, Lai TY, Tam BS, Liu DT, Chan CK. Choroidal vascular remodelling in central serous chorioretinopathy after indocyanine green-guided photodynamic therapy with verteporfin: A novel treatment at the primary disease level. Br J Ophthalmol 2003;87:1453-1458.
109. Lai TY, Chan WM, Li H, Lai RY, Liu DT, Lam DS. Safetyenhanced photodynamic therapy with half dose verteporfin for chronic central serous chorioretinopathy: A short term pilot study. Br J Ophthalmol 2006;90:869-874.
110. Chan WM, Lai TY, Lai RY, Liu DT, Lam DS. Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: One-year results of a randomized controlled trial. Ophthalmology 2008;115:1756-1765.
111. Reibaldi M, Boscia F, Avitabile T, et al. Low-fluence photodynamic therapy in longstanding chronic central serous chorioretinopathy with foveal and gravitational atrophy. Eur J Ophthalmol 2009;19:154-158.
112. Inoue R, Sawa M, Tsujikawa M, Gomi F. Association between the efficacy of photodynamic therapy and indocyanine green angiography findings for central serous chorioretinopathy. Am J Ophthalmol 2010;149:441-446.
113. Yannuzzi LA. Central serous chorioretinopathy: A personal perspective. Am J Ophthalmol 2010;149:361-363.
114. Shields CL, Shields JA, De Potter P. Patterns of indocyanine green videoangiography of choroidal tumours. Br J Ophthalmol 1995;79:237-245.
115. Snyers B, De Potter P. Advantages of digital indocyanine green angiography for diagnosing choroidal tumors [French]. J Fr Ophtalmol 2002;25:212-220.
116. Bonnet M, Habozit F, Magnard G. The value of infrared angiography with indocyanine green in the clinical diagnosis of angiomas of the choroids (anatomo-clinical report) [French]. Bull Soc Ophtalmol Fr 1976;76:713-716.
117. Arevalo JF, Shields CL, Shields JA, Hykin PG, De Potter P. Circumscribed choroidal hemangioma: Characteristic features with indocyanine green videoangiography. Ophthalmology 2000;107:344-350.
118. Schalenbourg A, Piguet B, Zografos L. Indocyanine green angiographic findings in choroidal hemangiomas: A study of 75 cases. Ophthalmologica 2000;214:246-252.
119. Piccolino FC, Borgia L, Zinicola E. Indocyanine green angiography of circumscribed choroidal hemangiomas. Retina 1996;16:19-28.
120. Wen F, Wu D. Indocyanine green angiographic findings in diffuse choroidal hemangioma associated with Sturge-Weber syndrome. Graefes Arch Clin Exp Ophthalmol 2000;238: 625-627.
121. Barbazetto I, Schmidt-Erfurth U. Photodynamic therapy of choroidal hemangioma: Two case reports. Graefes Arch Clin Exp Ophthalmol 2000;238:214-221.
122. Boixadera A, García-Arumí J, Martínez-Castillo V, et al. Prospective clinical trial evaluating the efficacy of photodynamic therapy for symptomatic circumscribed choroidal hemangioma. Ophthalmology 2009;116:100-105.
123. Mosci C, Polizzi A, Zingirian M; Genova Ocular Oncology Study Group. Transpupillary thermotherapy for circumscribed choroidal hemangiomas: First choice in therapy. Eur J Ophthalmol 2001;11:316-318.
124. De Laey JJ. Diagnosis and differential diagnosis of malignant melanomas of the choroid. Bull Soc Belge Ophtalmol 1993; 248:6-10.
125. Andersen MV, Scherfig E, Prause JU. Differential diagnosis of choroidal melanomas and nevi using scanning laser ophthalmoscopical indocyanine green angiography. Acta Ophthalmol Scand 1995;73:453-456.
126. Sallet G, Amoaku WM, Lafaut BA, Brabant P, De Laey JJ. Indocyanine green angiography of choroidal tumors. Graefes Arch Clin Exp Ophthalmol 1995;233:677-689.
127. Krause L, Bechrakis NE, Heinrich S, Kreusel KM, Foerster MH. Indocyanine green angiography and fluorescein angiography of malignant choroidal melanomas following proton beam irradiation. Graefes Arch Clin Exp Ophthalmol 2005; 243:545-550.
128. Kubicka-Trzaska A, Starzycka M, Romanowska-Dixon B. Indocyanine green angiography in the diagnosis of small choroidal tumours. Ophthalmologica 2002;216:316-319.
129. Mueller AJ, Bartsch DU, Schaller U, Freeman WR, Kampik A. Imaging the microcirculation of untreated and treated human choroidal melanomas. Int Ophthalmol 2001;23:385-393.
130. Frenkel S, Barzel I, Levy J, et al. Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography. Eye 2008;22:948-952.
131. Krause L, Bechrakis NE, Kreusel KM, Servetopoulou F, Heinrich S, Foerster MH. Indocyanine green angiography in choroid metastases [German]. Ophthalmologe 2002;99: 617-619.
132. Fardeau C, Lee CP, Merle-Béral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol 2009;147:886-894.
133. Giuffré G. Indocyanine green angiography in congenital hypertrophy of the retinal pigment epithelium. Eur J Ophthalmol 2005;15:162-164.
134. Koak N, Saatci AO, Kaynak S, Ergin MH, Ingil GC. Indocyanine green angiography of retinal astrocytomas associated with tuberous sclerosis. Korean J Ophthalmol 2003;17:145-148.
135. Lafaut BA, Mestdagh C, Kohno T, Gaudric A, De Laey JJ. Indocyanine green angiography in choroidal osteoma. Graefes Arch Clin Exp Ophthalmol 1997;235:330-337.
136. Ie D, Glaser BM, Murphy RP, Gordon LW, Sjaarda RN, Thompson JT. Indocyanine green angiography in multiple evanescent white-dot syndrome. Am J Ophthalmol 1994;117: 7-12.
137. Pece A, Sadun F, Trabucchi G, Brancato R. Indocyanine green angiography in enlarged blind spot syndrome. Am J Ophthalmol 1998;126:604-607.
138. Martinet V, Ducos de Lahitte G, Terrada C, Simon C, LeHoang P, Bodaghi B. Multiple evanescent white dot syndrome and acute idiopathic blind spot enlargement: Angiographic and electrophysiologic findings [French]. J Fr Ophtalmol 2008;31:265-272.
139. Obana A, Kusumi M, Miki T. Indocyanine green angiographic aspects of multiple evanescent white dot syndrome. Retina 1996;16:97-104.
140. Gross NE, Yannuzzi LA, Freund KB, Spaide RF, Amato GP, Sigal R. Multiple evanescent white dot syndrome. Arch Ophthalmol 2006;124:493-500.
141. Dell'omo R, Wong R, Marino M, Konstantopoulou K, Pavesio C. Relationship between different fluorescein and indocyanine green angiography features in multiple evanescent white dot syndrome. Br J Ophthalmol 2010;94:59-63.
142. Tsukamoto E, Yamada T, Kadoi C, Hayasaka S, Nagaki Y, Hayasaka Y. Hypofluorescent spots on indocyanine green angiography at the recovery stage in multiple evanescent white dot syndrome. Ophthalmologica 1999;213:336-338.
143. Slakter JS, Giovannini A, Yannuzzi LA, et al. Indocyanine green angiography of multifocal choroiditis. Ophthalmology 1997;104:1813-1819.
144. Vadalá M, Lodato G, Cillino S. Multifocal choroiditis: Indocyanine green angiographic features. Ophthalmologica 2001;215:16-21.
145. Cimino L, Auer C, Herbort CP. Sensitivity of indocyanine green angiography for the follow-up of active inflammatory choriocapillaropathies. Ocul Immunol Inflamm 2000;8: 275-283.
146. Howe LJ, Woon H, Graham EM, Fitzke F, Bhandari A, Marshall J. Choroidal hypoperfusion in acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiography study. Ophthalmology 1995;102:790-798.
147. Park D, Schatz H, McDonald HR, Johnson RN. Indocyanine green angiography of acute multifocal posterior placoid pigment epitheliopathy. Ophthalmology 1995;102:1877-1883.
148. Yuzawa M, Kawamura A, Matsui M. Indocyanine green video angiographic findings in acute posterior multifocal placoid pigment epitheliopathy. Acta Ophthalmol 1994;72:128-133.
149. Dhaliwal RS, Maguire AM, Flower RW, Arribas NP. Acute posterior multifocal placoid pigment epitheliopathy. An indocyanine green angiographic study. Retina 1993;13: 317-325.
150. Oshima Y, Harino S, Hara Y, Tano Y. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 1996;122:58-66.
151. Yuzawa M, Kawamura A, Matsui M. Indocyanine green video-angiographic findings in Harada's disease. Jpn J Ophthalmol 1993;37:456-466.
152. Wu W, Wen F, Huang S, Luo G, Wu D. Indocyanine green angiographic findings of Dalen-Fuchs nodules in Vogt- Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 2007;245:937-940.
153. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt- Koyanagi-Harada disease. Ophthalmology 2001;108:54-64.
154. Kawaguchi T, Horie S, Bouchenaki N, Ohno-Matsui K, Mochizuki M, Herbort CP. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2010;30: 41-50.
155. Giovannini A, Mariotti C, Ripa E, Scassellati-Sforzolini B. Indocyanine green angiographic findings in serpiginous choroidopathy. Br J Ophthalmol 1996;80:536-540.
156. Salati C, Pantelis V, Lafaut BA, Sallet G, De Laey JJ. A 8- month indocyanine angiographic follow-up of a patient with serpiginous choroidopathy. Bull Soc Belge Ophtalmol 1997; 265:29-33.
157. Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol 2005;50:231-244.
158. Giovannini A, Ripa E, Scassellati-Sforzolini B, Ciardella A, Tom D, Yannuzzi L. Indocyanine green angiography in serpiginous choroidopathy. Eur J Ophthalmol 1996;6: 299-306.
159. Spaide RF. Collateral damage in acute zonal occult outer retinopathy. Am J Ophthalmol 2004;138:887-889.
160. Trinh L, Bodaghi B, Fardeau C, et al. Clinical features, treatment methods, and evolution of birdshot chorioretinopathy in 5 different families. Am J Ophthalmol 2009;147: 1042-1047.
161. Fardeau C, Herbort CP, Kullmann N, Quentel G, LeHoang P. Indocyanine green angiography in birdshot chorioretinopathy. Ophthalmology 1999;106:1928-1934.
162. Howe LJ, Stanford MR, Graham EM, Marshall J. Choroidal abnormalities in birdshot chorioretinopathy: An indocyanine green angiography study. Eye 1997;11:554-559.
163. Akova YA, Kadayifcilar S, Aydin P. Assessment of choroidal involvement in sarcoidosis with indocyanine green angiography. Eye 1999;13:601-603.
164. Wolfensberger TJ, Herbort CP. Indocyanine green angiographic features in ocular sarcoidosis. Ophthalmology 1999; 106:285-289.
165. Matsuo T, Sato Y, Shiraga F, Shiragami C, Tsuchida Y. Choroidal abnormalities in Behcxet disease observed by simultaneous indocyanine green and fluorescein angiography with scanning laser ophthalmoscopy. Ophthalmology 1999; 106:295-300.
166. Bozzoni-Pantaleoni F, Gharbiya M, Pirraglia MP, Accorinti M, Pivetti-Pezzi P. Indocyanine green angiographic findings in Behcxet disease. Retina 2001;21:230-236.
167. Wolfensberger TJ, Piguet B, Herbort CP. Indocyanine green angiographic features in tuberculous chorioretinitis. Am J Ophthalmol 1999;127:350-353.
168. Guex-Crosier Y, Auer C, Bernasconi O, Herbort CP. Toxoplasmic retinochoroiditis: Resolution without treatment of the perilesional satellite dark dots seen by indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol 1998; 236:476-478.
169. Auer C, Bernasconi O, Herbort CP. Toxoplasmic retinochoroiditis: New insights provided by indocyanine green angiography. Am J Ophthalmol 1997;123:131-133.
170. Khairallah M, Ben Yahia S, Attia S, et al. Indocyanine green angiographic features in multifocal chorioretinitis associated with West Nile virus infection. Retina 2006;26:358-359.
171. Bacsal KE, Chee SP, Cheng CL, Flores JV. Dengue-associated maculopathy. Arch Ophthalmol 2007;125:501-510.
172. Joseph A, Rogers S, Browning A, et al. Syphilitic acute posterior placoid chorioretinitis in nonimmuno-compromised patients. Eye 2007;21:1114-1119.
173. Vianna RN, Onofre G, Ecard V, Muralha L, Muralha A, de A Garcia CA. Indocyanine green angiography in diffuse unilateral subacute neuroretinitis. Eye 2006;20:1113-1116.
174. Kuznik-Borkowska A, Cohen SY, Broïdo-Hooreman O, Gaudric A. Acute macular neuroretinopathy [French]. J Fr Ophtalmol 2006;29:319-322.
175. Gómez-Torreiro M, Gómez-Ulla F, Bolívar Montesa P, Rodriguez-Cid MJ. Scanning laser opthalmoscope findings in acute macular neuroretinopathy. Retina 2002;22:108-109.
176. Gharbiya M, Pecci G, Baglio V, Gargiulo A, Allievi F, Balacco-Gabrieli C. Indocyanine green angiographic findings for patients with systemic lupus erythematosus nephropathy. Retina 2006;26:159-164.
177. Gharbiya M, Bozzoni-Pantaleoni F, Augello F, Balacco- Gabrieli C. Indocyanine green angiographic findings in systemic lupus erythematosus choroidopathy. Am J Ophthalmol 2002;134:286-290.
178. Moshfeghi AA, Harrison SA, Ferrone PJ. Indocyanine green angiography findings in sympathetic ophthalmia. Ophthalmic Surg Lasers Imaging 2005;36:163-166.
179. Samuel MA, Equi RA, Chang TS, et al. Idiopathic retinitis, vasculitis, aneurysms, and neuroretinitis (IRVAN): New observations and a proposed staging system. Ophthalmology 2007;114:1526-1529.
180. Gharbiya M, Pantaleoni FB, Accorinti M, Pezzi PP. Indocyanine green angiography in a case of idiopathic retinal vasculitis, aneurysms and neuroretinitis. Eye 2000;14: 655-659.
181. Martinet N, Fardeau C, Adam R, et al. Fluorescein and indocyanine green angiographies in Susac syndrome. Retina 2007;27:1238-1242.
182. Auer C, Herbort CP. Indocyanine green angiographic features in posterior scleritis. Am J Ophthalmol 1998;126:471-476.
183. Tugal-Tutkun I, Herbort CP, Khairallah M; The Angiography Scoring for Uveitis Working Group (ASUWOG). Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol 2010;30:539-552.
184. Wroblewski JJ, Gitter KA, Cohen G, Schomaker K. Indocyanine green angiography in Stargardt's flavimaculatus. Am J Ophthalmol 1995;120:208-218.
185. Schwoerer J, Secrétan M, Zografos L, Piguet B. Indocyanine green angiography in Fundus flavimaculatus. Ophthalmologica 2000;214:240-245.
186. Souied EH, Goritsa A, Querques G, Coscas G, Soubrane G. Indocyanine green angiography of juvenile X-linked retinoschisis. Am J Ophthalmol 2005;140:558-561.
187. Lanzetta P, Virgili G, Menchini U. Indocyanine green angiography in vitelliform macular lesions. Ophthalmologica 1996;210:189-194.
188. Battaglia Parodi M, Iustulin D, Russo D, Ravalico G. Adultonset foveomacular vitelliform dystrophy and indocyanine green videoangiography. Graefes Arch Clin Exp Ophthalmol 1996;234:208-211.
189. Lip PL, Good PA, Gibson JM. Sorsby's fundus dystrophy: A case report of 24 years follow-up with electrodiagnostic tests and indocyanine green angiography. Eye 1999;13: 16-25.
190. Lafaut BA, De Backer E, Kohno T, De Laey JJ, Meire FM. Indocyanine green angiography in Sorsby's fundus dystrophy. Graefes Arch Clin Exp Ophthalmol 2000;238:158-162.
191. Souied EH, Leveziel N, Querques G, Darmon J, Coscas G, Soubrane G. Indocyanine green angiography features of Malattia leventinese. Br J Ophthalmol 2006;90:296-300.
192. Saatci AO, Yaman A, Oner FH, Ergin MH, Cingil G. Indocyanine green angiography in Bietti's crystalline retinopathy. Can J Ophthalmol 2002;37:346-351.
193. Kohno T, Miki T, Hayashi K. Choroidopathy after blunt trauma to the eye: A fluorescein and indocyanine green angiographic study. Am J Ophthalmol 1998;126:248-260.
194. Masaoka N, Sawada K, Komatsu T, Fukushima A, Ueno H. Indocyanine green angiographic findings in 3 patients with traumatic hypotony maculopathy. Jpn J Ophthalmol 2000;44: 283-289.
195. Kohno T, Miki T, Shiraki K, Kano K, Hirabayashi-Matsushita M. Indocyanine green angiographic features of choroidal rupture and choroidal vascular injury after contusion ocular injury. Am J Ophthalmol 2000;129:38-46.
196. Baltatzis S, Ladas ID, Panagiotidis D, Theodossiadis GP. Multiple post-traumatic choroidal ruptures obscured by hemorrhage: Imaging with indocyanine green angiography. Retina 1997;17:352-354.
197. Querques G, Coscas G, Soubrane G, Souied EH. Type II idiopathic macular telangiectasia and soft confluent drusen. Eur J Ophthalmol 2010;20:466-468.
198. Bourhis A, Girmens JF, Boni S, et al. Imaging of macroaneurysms occurring during retinal vein occlusion and diabetic retinopathy by indocyanine green angiography and high resolution optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2010;248:161-166.
199. Kawazoe M, Hirata A, Okinami S. Fluorescein and indocyanine green angiographic findings in progressive hemifacial atrophy. J Pediatr Ophthalmol Strabismus 2009; 46:56-58.
200. Diallo JW, Kuhn D, Haymann-Gawrilow P, Soubrane G. Contribution of indocyanine green angiography in sickle cell retinopathy [French]. J Fr Ophtalmol 2009;32:430-435.
201. Gomez-Ulla F, Fente B, Torreiro MG, Salorio MS, Gonzalez F. Choroidal vascular abnormality in Purtscher's retinopathy shown by indocyanine green angiography. Am J Ophthalmol 1996;122:261-263.
202. Haruyama M, Yuzawa M, Kawamura A, Yamazaki C, Matsumoto Y. Indocyanine green angiographic findings of chorioretinal folds. Jpn J Ophthalmol 2001;45:293-300.
203. Yasunari T, Shiraki K, Hattori H, Miki T. Frequency of choroidal abnormalities in neurofibromatosis type 1. Lancet 2000;356:988-992.
204. Pece A, Yannuzzi L, Sannace C, Scassellati Sforzolini B, Brancato R. Chorioretinal involvement in primary systemic nonfamilial amyloidosis. Am J Ophthalmol 2000;130: 250-253.
205. Townsend-Pico WA, Meyers SM, Lewis H. Indocyanine green angiography in the diagnosis of retinal arterial macroaneurysms associated with submacular and preretinal hemorrhages: A case series. Am J Ophthalmol 2000;129:33-37.
206. Valluri S, Adelberg DA, Curtis RS, Olk RJ. Diagnostic indocyanine green angiography in pre-eclampsia. Am J Ophthalmol 1996;122:672-677.
207. Spaide RF, Leys A, Herrmann-Delemazure B, et al. Radiation- associated choroidal neovasculopathy. Ophthalmology 1999;106:2254-2260.
208. Singh AD, De Potter P, Shields CL, Shields JA. Indocyanine green angiography and ultrasonography of a varix of vortex vein. Arch Ophthalmol 1993;111:1283-1284.
209. Gündüz K, Shields CL, Shields JA. Varix of the vortex vein ampulla simulating choroidal melanoma: Report of four cases. Retina 1998;18:343-347.
210. Kang HK, Beaumont PE, Chang AA. Indocyanine green angiographic features of varix of the vortex vein ampulla. Clin Experiment Ophthalmol 2000;28:321-323.